Table. 1.

Table. 1.

Revised classification of histiocytosis and neoplasms of the macrophage-dendritic cell lineage

Group Disease
L Group Langerhans cell histiocytosis (LCH)
Indeterminate cell histiocytosis (ICH)
Erdheim-Chester disease (ECD)
Mixed LCH/ECD
C Group Cutaneous non-LCH
- XG family: JXG, AXG, SRH, BCH, GEH, PNH
- N-XG family: cutaneous RDD, NXG, other NOS
Cutaneous non-LCH with major systemic component
R group Familial Rosai-Dorfman Disease (RDD)
Sporadic RDD
- Classical RDD
- Extra-nodal RDD
- RDD with neoplasia or immune disease
- Unclassified
M group Primary malignant histiocytosis
Secondary malignant histiocytosis
H group Primary hemophagocytic lymphohistiocytosis (HLH)
Secondary HLH
HLH of unknown/uncertain origin

AXG, adult xanthogranuloma; BCH, benign cephalic histiocytosis; GEH, generalized eruptive histiocytosis; JXG, juvenile xanthogranuloma; NXG, necrobiotic xanthogranuloma; PNH, progressive nodular histiocytosis; SRH, solitary reticulohistiocytoma. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages [5].

Clin Pediatr Hematol Oncol 2020;27:32-42
© 2020 Clin Pediatr Hematol Oncol